Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3866381013 | Brolucizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3866382018 | Product containing only brolucizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2864321000001117 | Brolucizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2864341000001110 | Brolucizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brolucizumab | Is a | Product containing brolucizumab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab | Has active ingredient | Brolucizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Brolucizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only brolucizumab in parenteral dose form (medicinal product form) | Is a | True | Brolucizumab | Inferred relationship | Existential restriction modifier | |
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes | Is a | True | Brolucizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR